REGULUS THERAPEUTICS INC.

SAN DIEGO, CA How do I update this listing?

Regulus Therapeutics is based out of San Diego. Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of microRNA therapeutics to treat a range of diseases primarily in the United States. The company is developing various oligonucleotides, including miR-21 for hepatocellular carcinoma and for kidney fibrosis, miR-122 for hepatitis C virus infection, miR-33 for atherosclerosis, and miR-10b for glioblastoma multiforme treatment.Whalewisdom has at least 1 13G filings, and 118 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-12-17. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

regulus therapeutics inc.
4224 CAMPUS POINT COURT
SAN DIEGO CA    92121

Business Phone: 858-202-6300
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-12-17 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 34,537,555 19,383,037 15,154,518
2019-05-14 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 79,343,959 16,736,889 62,607,070
2014-02-06 D BIOTECHNOLOGY Equity 9,999,992 9,999,992 0
2012-10-23 D PHARMACEUTICALS Equity 25,000,000 25,000,000 0
2012-10-23 D PHARMACEUTICALS Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,000,000 5,000,000 0
2010-11-15 D PHARMACEUTICALS Equity 29,800,000 29,800,000 0
2010-11-15 D PHARMACEUTICALS Equity 20,000,000 20,000,000 0
2010-11-15 D PHARMACEUTICALS Equity 9,999,996 9,999,996 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
B. LYNNE PARSHALL subscription required
    DIRECTOR
BARRY E. GREENE subscription required
    DIRECTOR
BRUCE L.A. CARTER subscription required
    DIRECTOR
CHRISTOPHER AKER subscription required
    EXECUTIVE OFFICER
CRIS CALSADA subscription required
    EXECUTIVE OFFICER
DANIEL R. CHEVALLARD subscription required
    EXECUTIVE OFFICER
DAVID BALTIMORE subscription required
    DIRECTOR
DENIS DRYGIN subscription required
    EXECUTIVE OFFICER
DOUGLAS E. WILLIAMS subscription required
    DIRECTOR
GARRY MENZEL subscription required
    EXECUTIVE OFFICER
GRANTLAND BRYCE subscription required
    EXECUTIVE OFFICER
HUGH ROSEN subscription required
    DIRECTOR
JAKE R. NUNN subscription required
    DIRECTOR
JOHN MARAGANORE subscription required
    DIRECTOR
JOSEPH P. HAGAN subscription required
    EXECUTIVE OFFICER DIRECTOR
KATHRYN L. COLLIER subscription required
    DIRECTOR
KLEANTHIS XANTHOPOULOS subscription required
    EXECUTIVE OFFICER DIRECTOR
MARK G. FOLETTA subscription required
    DIRECTOR
NEIL GIBSON subscription required
    EXECUTIVE OFFICER
PASCALE WITZ subscription required
    DIRECTOR
SIMOS SIMEONIDIS subscription required
    DIRECTOR
STANLEY CROOKE subscription required
    DIRECTOR
STELIOS PAPADOPOULOS subscription required
    DIRECTOR
WILLIAM H. RASTETTER subscription required
    DIRECTOR

Elevate your investments